Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss

NCT04701333 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Lactation Suppressed

Interventions

DRUG: Cabergoline 1 MG
DRUG: Placebo

Sponsor

Stanford University